Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Hostname: page-component-559fc8cf4f-6f8dk Total loading time: 0.439 Render date: 2021-03-01T21:03:42.999Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }
EnglishFrançais
Advances in Psychiatric Treatment Advances in Psychiatric Treatment

Article contents

Pharmacotherapy in the treatment of drug dependence: options to strengthen effectiveness

Published online by Cambridge University Press:  02 January 2018

Sarah Welch  and
John Strang
Save pdf (2 mb)
Rights & Permissions[Opens in a new window]

Extract

Treatment of people with drug problems requires a consideration of those inviduals in their personal and social context, while being mindful of the complex interaction of genetic and developmental influences. Approaches to treatment should reflect this often complex aetiology and phenomenology, and the totality of treatment will typically include social, psychological, educational and pharmacological therapies. Treatment should result in a health benefit; consequently the goals of treatment should be tailored to the health care needs of the individual. Thus, with many patients, treatment will include abstinence as an explicit objective, whereas with other patients, intermediate goals, such as reduction of harmful injecting, may be more realistic and achievable.

Type
Research Article
Information
Advances in Psychiatric Treatment , Volume 5 , Issue 6 , November 1999 , pp. 427 - 434
Copyright
Copyright © The Royal College of Psychiatrists 1999 

References

Advisory Council on the Misuse of Drugs (1988) AIDS and Drug Misuse Report: Part I. London: HMSO.Google Scholar
Bammer, G. (1993) Should the controlled provision of heroin be a treatment option? Australian feasibility considerations. Addiction, 88, 467–475.Google ScholarPubMed
Bearn, J., Gossop, M. & Strang, J. (1996) Randomised double-blind comparison of lofexidine and methadone in the inpatient treatment of opiate withdrawal. Drug and Alcohol Dependence, 43, 87–91.CrossRefGoogle Scholar
Carnwath, T. & Hardman, J. (1998) Randomised double-blind comparison of lofexidine and clonidine in the outpatient treatment of opiate withdrawal. Drug and Alcohol Dependence, 50, 251–254.CrossRefGoogle ScholarPubMed
Darke, S., Ross, J. & Hall, W. (1996) Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction, 91, 405–411.CrossRefGoogle ScholarPubMed
Darke, S. & Hall, W. (1997) The distribution of naloxone to heroin users. Addiction, 92, 1195–1199.CrossRefGoogle ScholarPubMed
Fleming, P. M. & Roberts, D. (1994) Is the prescription of amphetamine justified as a harm reduction measure? Journal of the Royal Society of Health, 114, 127–131.CrossRefGoogle ScholarPubMed
Gossop, M., Johns, A. & Green, L. (1986) Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment. British Medical Journal, 293, 103–104.CrossRefGoogle ScholarPubMed
Gossop, M., Griffiths, P., Bradley, B. et al (1989) Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. British Journal of Psychiatry, 154, 360–363.CrossRefGoogle ScholarPubMed
Gossop, M., Griffiths, P., Powis, B. et al (1996) Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. British Medical Journal, 313, 402.CrossRefGoogle ScholarPubMed
Gossop, M., Marsden, J., Stewart, D. et al (1997) The National Treatment Outcome Research Study in the United Kingdom: Six-month follow-up outcomes. Psychology of Addictive Behaviors, 11, 324–337.CrossRefGoogle Scholar
Hammersley, R., Lavelle, T. & Forsyth, A. (1990) Buprenorphine and temazepam abuse. British Journal of Addiction, 85, 301–302.CrossRefGoogle ScholarPubMed
Hawks, D., Mitcheson, M., Ogborne, A. et al (1969) Abuse of methylamphetamine. British Medical Journal, 2, 715–721.CrossRefGoogle ScholarPubMed
Hendra, T. J., Gerrish, S. P. & Forrest, A. R. (1996) Fatal methadone overdose. British Medical Journal, 313, 481–482.CrossRefGoogle ScholarPubMed
Kahn, A., Mumford, J. P., Rogers, G.A. et al (1997) Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. Drug and Alcohol Dependence, 44, 57–61.CrossRefGoogle ScholarPubMed
Kleber, H. D., Riordan, C. E., Rounsaville, B. et al (1985) Clonidine in outpatient detoxification from methadone maintenance. Archives of General Psychiatry, 42, 391–394.CrossRefGoogle ScholarPubMed
Kosten, T. R. & Kleber, H. D. (1984) Strategies to improve compliance with narcotic antagonists. American Journal of Drug and Alcohol Abuse, 10, 249–266.CrossRefGoogle ScholarPubMed
Lader, M. & Morton, S. (1991) Benzodiazepine problems British Journal of Addiction, 86, 823–828.CrossRefGoogle ScholarPubMed
Ling, W., Rawson, R. A. & Compton, M. A. (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. Journal of Psychoactive Drugs, 26, 119–28.CrossRefGoogle ScholarPubMed
Lobl, J. K. & Carbone, L. D. (1992) Emergency management of cocaine intoxication. Counteracting the effects of today's ‘favorite drug’. Postgraduate Medicine, 91, 161–162, 165–166.CrossRefGoogle ScholarPubMed
Marlatt, G. A. & George, W. H. (1984) Relapse prevention: introduction and overview of the model. British Journal of Addiction, 79, 261–275.CrossRefGoogle ScholarPubMed
Marsch, L. A. (1998) The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: a meta-analysis. Addiction, 93, 515–532.CrossRefGoogle ScholarPubMed
Mitcheson, M., Edwards, G., Hawks, D. et al (1976) Treatment of methylamphetamine users during the 1968 epidemic. In Drugs and Drug Dependence (eds Edwards, G., Russell, M. A. H., Hawks, D. et al). Farnborough: Saxon House.Google Scholar
Perneger, T. V., Giner, F., del Rio, M. et al (1998) Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13–18.CrossRefGoogle ScholarPubMed
Raistrick, D., Hay, A. & Wolff, K. (1996) Methadone maintenance and tuberculosis treatment. British Medical Journal, 313, 925–926.CrossRefGoogle ScholarPubMed
Strang, J. (1990) Intermediate goals and the process of change. In AIDS and Drug Misuse: The Challenge for Policy and Practice in the 1990s (eds Strang, J. & Stimson, G.) pp. 211–221. London: Routledge.Google Scholar
Strang, J. (1992) Harm reduction for drug users: exploring the dimensions of harm, their measurement and strategies for their reduction. AIDS and Public Policy Journal, 7, 145–152.Google Scholar
Strang, J., Darke, S., Hall, W. et al (1996a) Heroin overdose: the case for take-home naloxone. British Medical Journal, 312, 1435–1436.CrossRefGoogle ScholarPubMed
Strang, J., Sheridan, J. & Barber, N. (1996b) Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. British Medical Journal, 313, 270–272.CrossRefGoogle ScholarPubMed
Strang, J., Sheridan, J. (1997a) Heroin prescribing in the British system of the mid-1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug and Alcohol Review, 16, 7–16.CrossRefGoogle ScholarPubMed
Strang, J., Sheridan, J. (1997b) Prescribing amphetamines to drug misusers: Data from the 1995 national survey of community pharmacies in England and Wales. Addiction, 92, 833–838.CrossRefGoogle ScholarPubMed
Strang, J., Marks, I., Dawe, S. et al (1997a) Type of hospital setting and treatment outcome with heroin addicts. Results from a randomised trial. British Journal of Psychiatry, 171, 335–339.CrossRefGoogle ScholarPubMed
Strang, J., Bearn, J. & Gossop, M. (1997b) Opiate detoxification under anaesthesia. British Medical Journal, 315, 1249–1250.CrossRefGoogle ScholarPubMed
Strang, J., Finch, E., Hankinson, L. et al (1997c) Methadone treatment for opiate addiction: benefits in the first month. Addiction Research, 5, 71–76.CrossRefGoogle Scholar
Strang, J., Powis, B., Best, D. et al (1999) Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction, 94, 199–204.CrossRefGoogle ScholarPubMed
Vining, E., Kosten, T. R. & Kleber, H. D. (1988) Clinical utility of rapid clonidine–naltrexone detoxification for opioid abusers. British Journal of Addiction, 83, 567–575.CrossRefGoogle ScholarPubMed
Ward, J., Darke, S., Hall, W. et al (1992) Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. British Journal of Addiction, 87, 447–453.CrossRefGoogle ScholarPubMed
Weinbroum, A. A., Flaishon, R., Sorkine, P. et al (1997) A risk–benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Safety, 17, 181–96.CrossRefGoogle ScholarPubMed
World Health Organization (1992) ICD–10 Classification of Mental and Behaviour Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 133 *
View data table for this chart

* Views captured on Cambridge Core between 02nd January 2018 - 1st March 2021. This data will be updated every 24 hours.

Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Pharmacotherapy in the treatment of drug dependence: options to strengthen effectiveness
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Pharmacotherapy in the treatment of drug dependence: options to strengthen effectiveness
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Pharmacotherapy in the treatment of drug dependence: options to strengthen effectiveness
Available formats
×
×

Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *